Oseltamivir Pharmacokinetic Cohort Study

Completed

• Conditions: flu; Influenza; 10047438

• Registration Number: NL-OMON32852
• Lead Sponsor: Slotervaartziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 80

Inclusion Criteria

- Child <13 years or adult with significant co-morbidities
- Oseltamivir treatment
- Hospitilisation

Exclusion Criteria

- No written informed consent
- Unable to fulfil study procedures
- Difficult to obtain blood samples

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Pharmacokinetics</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Adverse events<br /><br>Oropharyngeal viral load</p><br>